NMRA Competitors & Alternatives
Compare Neumora Therapeutics, Inc. with similar stocks in the same industry
Biotechnology
NMRA
Main Stock$1.84
Tradestie Score
51
Market Cap
$288.26M
Analyst Upside
+384.1%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$9.15
|
$407.71M | - | 55 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$14.37
|
$386.68M | - | 55 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.74
|
$382.04M | - | 52 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$10.36
|
$371.64M | - | 59 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$28.79
|
$357.51M | - | 56 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$15.73
|
$354.45M | - | 57 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$29.66
|
$353.70M | - | 47 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.66
|
$350.98M | - | 51 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.85
|
$341.56M | - | 60 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.21
|
$332.96M | - | 48 | Compare |
More NMRA Analysis
Data updated: May 16, 2026 | Industry: Biotechnology (SIC 2836)
228 stocks in this industry